---
title: "HealthWarehouse.com Reports Results for First Quarter 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285991598.md"
description: "HealthWarehouse.com, Inc. revealed that its net sales for the first quarter ending March 31, 2026, were $6.3 million, marking a 58% drop compared to the same period in 2025. This decline was attributed to the conclusion of a nationwide shortage by the U.S. Food and Drug Administration, which had permitted pharmacies to produce and sell compounded GLP-1 prescription drugs when brand-name options were scarce. The company reported a net loss of $361,000 and an Adjusted EBITDA figure that was negative."
datetime: "2026-05-11T20:09:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285991598.md)
  - [en](https://longbridge.com/en/news/285991598.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285991598.md)
---

# HealthWarehouse.com Reports Results for First Quarter 2026

HealthWarehouse.com, Inc. revealed that its net sales for the first quarter ending March 31, 2026, were $6.3 million, marking a 58% drop compared to the same period in 2025. This decline was attributed to the conclusion of a nationwide shortage by the U.S. Food and Drug Administration, which had permitted pharmacies to produce and sell compounded GLP-1 prescription drugs when brand-name options were scarce. The company reported a net loss of $361,000 and an Adjusted EBITDA figure that was negative.

### Related Stocks

- [HCWC.US](https://longbridge.com/en/quote/HCWC.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XHS.US](https://longbridge.com/en/quote/XHS.US.md)

## Related News & Research

- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [BioMarin's drug shows significant growth gains in children in late-stage trial](https://longbridge.com/en/news/287121584.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)